Celera Group, a molecular diagnostics company, engages in the discovery and validation of novel diagnostic markers, using proprietary genomics and proteomics discovery platforms. It is also developing diagnostic products based on these markers. The company, through its strategic alliance with Abbott Laboratories, manufactures and sells six product groups, including ViroSeq HIV-1 Genotyping System, an aid to physicians in monitoring and treating HIV-1 infection; products that are used for the detection of mutations in the cystic fibrosis transmembrane conductance regulator gene, which cause cystic fibrosis; two types of hepatitis C virus analyte specific reagents (ASRs); ASRs for the...